Preview

This is your website preview.

Currently it only shows your basic business info. Start adding relevant business details such as description, images and products or services to gain your customers attention by using Boost 360 android app / iOS App / web portal.

STERISHEALTHCARE 573431969ec6680ff811d9bc Products https://www.sterisindia.com
  • 2023-12-25T13:01:00

Bicalutamide (50mg) BICALUMUTIDE 50 is a medication used in the treatment of prostate cancer. BICALUMUTIDE 50 is classified as an anti-androgen. It works by blocking the action of androgens, specifically testosterone, which can stimulate the growth of prostate cancer cells. BICALUMUTIDE 50 competitively inhibits the binding of androgens (male hormones) to androgen receptors in the prostate cells, thereby inhibiting the growth of prostate cancer. BICALUMUTIDE 50 is often long-term and may be continued for an extended period, depending on the progression of the disease. BICALUMUTIDE 50 may include hot flashes, breast tenderness or enlargement (gynecomastia), and gastrointestinal symptoms. BICALUMUTIDE 50 can affect liver function, and liver function tests may be monitored during treatment.BICALUMUTIDE 50 may cause an initial increase in testosterone levels, referred to as a "flare, " which is why it is often started in conjunction with LHRH agonists to prevent this effect. BICALUMUTIDE 50 will have regular follow-up appointments with their healthcare provider for monitoring of treatment effectiveness, side effects, and adjustments to treatment, if needed. BICALUMUTIDE 50 important for individuals prescribed Bicalutamide to follow their healthcare provider's instructions carefully, report any side effects promptly, and attend scheduled follow-up appointments for ongoing assessment and management of prostate cancer. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/bicalumutide-50-133654

Bicalutamide (50mg) BICALUMUTIDE 50 is a medication used in the treatment of prostate cancer. BICALUMUTIDE 50 is classified as an anti-androgen. It works by blocking the action of androgens, specifically testosterone, which can stimulate the growth of prostate cancer cells. BICALUMUTIDE 50 competitively inhibits the binding of androgens (male hormones) to androgen receptors in the prostate cells, thereby inhibiting the growth of prostate cancer. BICALUMUTIDE 50 is often long-term and may be continued for an extended period, depending on the progression of the disease. BICALUMUTIDE 50 may include hot flashes, breast tenderness or enlargement (gynecomastia), and gastrointestinal symptoms. BICALUMUTIDE 50 can affect liver function, and liver function tests may be monitored during treatment.BICALUMUTIDE 50 may cause an initial increase in testosterone levels, referred to as a "flare, " which is why it is often started in conjunction with LHRH agonists to prevent this effect. BICALUMUTIDE 50 will have regular follow-up appointments with their healthcare provider for monitoring of treatment effectiveness, side effects, and adjustments to treatment, if needed. BICALUMUTIDE 50 important for individuals prescribed Bicalutamide to follow their healthcare provider's instructions carefully, report any side effects promptly, and attend scheduled follow-up appointments for ongoing assessment and management of prostate cancer. Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 5 years we are dealing in Chronic Therapy and in 5 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us. For further information please contact: info@sterispharma.com order now:https://www.sterisonline.com/product/bicalumutide-50-133654

  • 2023-12-25T13:01:00

Have any question or need any business consultation?

Have any question or need any business consultation?

Contact Us
Chat with us